That’s fair, I’m not here to debate with anyone, I just like to know investors thoughts.
I don’t believe a CR was needed at this point in time.
But in time I don’t believe it will affect SH’s.
[INTERVIEW] A new drug class and commercialisation: what’s next for Actinogen?, page-36
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $63.54M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 1.9¢ | $126.5K | 6.326M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 600000 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 2811650 | 9 |
View Market Depth
| Last trade - 14.56pm 18/06/2025 (20 minute delay) ? |
| ACW (ASX) Chart |